The newer Cav1.3 VGCCs specific dihydropyridine derivate isradipine was shown to be neuroprotective in a mouse model of Parkinson disease [34] and was discussed as a potential strategy for the treatment of Alzheimer disease [35]. The gene discussed is CACNA1D; the disease is early-onset autosomal dominant Alzheimer disease.